Aerovate Therapeutics, Inc. AVTE
Trading inactive
AVTE
Aerovate Therapeutics, Inc. ACRV
Acrivon Therapeutics, Inc. Common Stock ADAG
Adagene Inc. ANAB
AnaptysBio, Inc. ANEB
Anebulo Pharmaceuticals, Inc. CTKB
Cytek Biosciences, Inc. DNTH
Dianthus Therapeutics, Inc. DSGN
Design Therapeutics, Inc. JBIO
Jade Biosciences, Inc. MLYS
Mineralys Therapeutics, Inc.
Aerovate Therapeutics, Inc. ACRV
Acrivon Therapeutics, Inc. Common Stock ADAG
Adagene Inc. ANAB
AnaptysBio, Inc. ANEB
Anebulo Pharmaceuticals, Inc. CTKB
Cytek Biosciences, Inc. DNTH
Dianthus Therapeutics, Inc. DSGN
Design Therapeutics, Inc. JBIO
Jade Biosciences, Inc. MLYS
Mineralys Therapeutics, Inc.
Performance
| Periode | AVTE | ACRV | ADAG | ANAB | ANEB | CTKB | DNTH | DSGN | JBIO | MLYS |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | -97.09 % | 18.00 % | 25.66 % | 81.75 % | 144.21 % | 5.32 % | 83.97 % | 99.69 % | -90.42 % | 209.27 % |
| YTD | -97.15 % | -68.89 % | -7.28 % | 142.96 % | 46.84 % | -39.73 % | 48.36 % | 5.19 % | -90.33 % | 251.43 % |
| 1Y | -99.52 % | -75.62 % | -13.57 % | -6.56 % | 26.78 % | -25.56 % | 35.35 % | 26.02 % | -87.86 % | 216.78 % |
| 3Y | -99.37 % | -89.36 % | 45.80 % | 22.40 % | -14.07 % | -72.48 % | 79.27 % | -58.87 % | -98.66 % | 133.46 % |
| 5Y | -99.66 % | -89.36 % | -93.63 % | 59.35 % | -67.32 % | -78.89 % | -70.69 % | -84.36 % | -98.86 % | 133.46 % |
| 10Y | -99.66 % | -89.36 % | -93.63 % | 90.94 % | -67.32 % | -78.89 % | -85.18 % | -84.36 % | -98.86 % | 133.46 % |
| From the beginning | -99.66 % | -89.36 % | -93.63 % | 90.94 % | -67.32 % | -78.89 % | -85.18 % | -84.36 % | -98.86 % | 133.46 % |